Telemedicine
OVERVIEW OF TELEMEDICINE
Telemedicine has primarily focused on initial consultations thus far, but the treatment of psoriasis poses distinctive difficulties that may require ongoing care for many years. Utilizing telemedicine opens possibilities for creating innovative strategies, including investigating artificial intelligence (AI) solutions and self-management of psoriasis care.
In 2020, IPC formed a working group to facilitate the growth and utilization of telemedicine for diagnosing and managing psoriasis. The Telemedicine Working Group, led by Alexander Navarrini as the chair and Joel Gelfand as the co-chair, has established a worldwide consensus statement on telemedicine’s role in psoriasis care, considering cultural and technological disparities. In addition, the working group will develop best practices for telemedicine in psoriasis treatment and educate dermatologists on the advantages and limitations of telemedicine.
Fast Facts
- The use of telemedicine for psoriasis care increased significantly during the COVID-19 pandemic, as many patients and healthcare providers had to limit in-person visits.
- Telemedicine may not be suitable for all patients with psoriasis, especially those with severe disease who require frequent or specialized medical care. In such cases, in-person care may still be necessary.
-
While telemedicine has many benefits for psoriasis patients, there are potential challenges, such as technical difficulties, privacy concerns, and limitations in performing specific medical procedures remotely.
IPC Resources
PUBLICATIONS AND RESEARCH
RESOURCES FOR PATIENTS
The Experts
Additional Resources
ARTICLES/OTHER RESOURCES
Below are resources from other organizations that support IPC’s recategorization of psoriasis severity.
American Telemedicine Association Practice Guidelines for Dermatology
Published: April 2016
Telemedicine: How to Prepare
Published by: American Academy of Dermatology Association.
Support Our Work
